PROX1 promotes secretory granule formation in medullary thyroid cancer cells

Endocrinology

Volumn 157, Issue 3, 2016, Pages 1289-1298

  Ishii, Jun ^a   Yazawa, Takuya ^b   Chiba, Tomohiro ^a   Shishido Hara, Yukiko ^c   Arimasu, Yuu ^a   Sato, Hanako ^d   Kamma, Hiroshi ^a  

^a KYORIN UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

^d ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYPEPTIDASE H; CHROMOGRANIN A; CHROMOGRANIN B; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; SECRETOGRANIN II; SECRETOGRANIN III; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CHROMOGRANIN; HOMEODOMAIN PROTEIN; PROSPERO-RELATED HOMEOBOX 1 PROTEIN; SCG2 PROTEIN, HUMAN; SCG3 PROTEIN, HUMAN; SYP PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANAPLASTIC THYROID CANCER; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL ULTRASTRUCTURE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; DEVELOPMENTAL GENE; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROX1 GENE; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETORY GRANULE; THYROID FOLLICLE CELL; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TRANSCRIPTION REGULATION; TRANSGENE; TRANSMISSION ELECTRON MICROSCOPY; VERY ELDERLY; ADENOCARCINOMA; ADENOMA; CARCINOMA; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; METABOLISM; SECRETORY VESICLE; THYROID GLAND; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ADULT; AGED; AGED, 80 AND OVER; CARBOXYPEPTIDASE H; CARCINOMA; CARCINOMA, NEUROENDOCRINE; CHROMATIN IMMUNOPRECIPITATION; CHROMOGRANIN A; CHROMOGRANIN B; CHROMOGRANINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCK-IN TECHNIQUES; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SECRETOGRANIN II; SECRETORY VESICLES; SYNAPTOPHYSIN; THYROID GLAND; THYROID NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84960511076     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1973     Document Type: Article

References (41)

1. Gilliland FD, Hunt WC, Morris DM, Key CR. Prognostic factors for thyroid carcinoma. A population-based study of 15 698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991. Cancer. 1997;79(3):564-573.
2. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. A National Cancer Data Base report on 53 856 cases of thyroid carcinoma treated in the US, 1985-1995. Cancer. 1998;83(12):2638-2648.
3. Roy M, Chen H, Sippel RS. Currentunderstandingandmanagement of medullary thyroid cancer. Oncologist. 2013;18(10):1093-1100.
4. Dannies PS. Protein hormone storage in secretory granules: mechanisms for concentration and sorting. Endocr Rev. 1999;20(1):3-21.
5. Arvan P, Castle D. Sorting and storage during secretory granule biogenesis: looking backward and looking forward. Biochem J. 1998;332(Pt 3):593-610.
6. Osamura RY, Yasuda O, Kawakami T, Itoh Y, Inada K, Kakudo K. Immunoelectron microscopic demonstration of regulated pathway for calcitonin and constitutive pathway for carcinoembryonic antigen in the same cells of human medullary carcinomas of thyroid glands. Mod Pathol. 1997;10(1):7-11.
7. Torii Ma, Matsuzaki F, Osumi N, et al. Transcription factors Mash-1 and Prox-1 delineate early steps in differentiation of neural stem cells in the developing central nervous system. Development. 1999;126(3):443-456.
8. Wigle JT, Chowdhury K, Gruss P, Oliver G. Prox1 functioniscrucial for mouse lens-fibre elongation. Nat Genet. 1999;21(3):318-322.
9. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell. 1999;17:98 (6) :769-778.
10. Burke Z, Oliver G. Prox1 is an early specific marker for the developing liver and pancreas inthe mammalian foregut endoderm. Mech Dev. 2002;118(1-2):147-155.
11. Risebro CA, Searles RG, Melville AA, et al. Prox1 maintains muscle structure and growth in the developing heart. Development. 2009;136(3):495-505.
12. Elsir T, Smits A, Lindström MS, Nistér M. Transcription factor PROX1: its role indevelopment and cancer. Cancer Metastasis Rev. 2012;31(3-4):793-805.
13. Kurebayashi J, Tanaka K, Otsuki T, et al. All-trans-retinoic acid modulates expression levelsof thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1. J Clin Endocrinol Metab. 2000;85(8):2889-2896.
14. Yano Y, Kamma H, Matsumoto H, et al. Growth suppression of thyroid cancer cells by adenylcyclase activator. Oncol Rep. 2007;18(2):441-445.
15. Ishii J, Sato H, Sakaeda M, et al. POU domain transcription factor BRN2iscrucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer. Pathol Int. 2013;63(3):158-168.
16. Kashiwagi K, Ishii J, Sakaeda M, et al. Differences of molecular expression mechanisms among neural cell adhesion molecule1, synaptophysin, and chromogranin A in lung cancer cells. Pathol Int. 2012;62(4):232-245.
17. Truman LA, A-Gonzalez N, Bentley KL, Ruddle NH. Lymphatic vessel function in head and neck inflammation. Lymphat Res Biol. 2013;11(3):187-192.
18. Inomoto C, Umemura S, Egashira N, et al. Granulogenesis in non-neuroendocrine COS-7 cells induced by EGFP-tagged chromogranin A gene transfection: identical and distinct distribution of CgA and EGFP. J Histochem Cytochem. 2007;55(5):487-493.
19. Kim T, Tao-Cheng JH, Eiden LE, Loh YP. Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell. 2001;24:106 (4) :499-509.
20. Pance A, Livesey FJ, Jackson AP. A role for the transcriptional repressor REST in maintaining the phenotype of neurosecretory-deficient PC12 cells. J Neurochem. 2006;99(5):1435-1444.
21. Jolma A, Yan J, Whitington T, et al. DNA-binding specificities of human transcription factors. Cell. 2013;152(1-2):327-339.
22. Hassan B, Li L, Bremer KA, Chang W, Pinsonneault J, Vaessin H. Prospero is a panneural transcription factor that modulates homeodomain protein activity. Proc Natl Acad Sci USA. 1997;94(20):10991-10996.
23. Chang TM, Hung WC. Transcriptional repression of TWIST1 gene by Prospero-related homeobox 1 inhibits invasiveness of hepatocellular carcinoma cells. FEBS Lett. 2012;586(20):3746-3752.
24. Ouyang H, Qin Y, Liu Y, Xie Y, Liu J. Prox1 directly interacts with LSD1 and recruits the LSD1/NuRD complex to epigenetically corepress CYP7A1 transcription. PLoS One. 2013;8(4):e6219223.
25. Nobels FR, Kwekkeboom DJ, Coopmans W, et al. Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the α-subunit of glycoprotein hormones. J Clin Endocrinol Metab. 1997;82(8):2622-2628.
26. Bernard N, Kitabgi P, Rovere-Jovene C. The Arg617-Arg618 cleavage site in the C-terminal domain of PC1 plays a major role in the processing and targeting of the enzyme within the regulated secretory pathway. J Neurochem. 2003;85(6):1592-1603.
27. Tsuboi T. Molecular mechanism of docking of dense-core vesicles to the plasma membrane in neuroendocrine cells. Med Mol Morphol. 2008;41(2):68-75.
28. Park JJ, Koshimizu H, Loh YP. Biogenesis and transport of secretory granules to release site in neuroendocrine cells. J Mol Neurosci. 2009;37(2):151-159.
29. Hendy GN, Li T, Girard M, et al. Targeted ablation of the chromogranin a (Chga) gene: normal neuroendocrine dense-core secretory granules and increased expression of other granins. Mol Endocrinol. 2006;20(8):1935-1947.
30. Eaton BA, Haugwitz M, Lau D, Moore HP. Biogenesis of regulated exocytotic carriers in neuroendocrine cells. J Neurosci. 2000;20(19):7334-7344.
31. Matsuda M, Yamamoto T-A, Hirata M. Ca2 +-dependent regulation of calcitonin gene expression by the transcriptional repressor DREAM. Endocrinology. 2006;147(10):4608-4617.
32. Monla YT, Peleg S, Gagel RF, Monia YT. Cell type-specific regulation of transcription by cyclic adenosine 3', 5'-monophosphateresponsive elements within the calcitonin promoter. Mol Endocrinol. 1995;9(7):784-793.
33. Thiagalingam A, De Bustros A, Borges M, et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol. 1996;16(10):5335-5345.
34. Suzuki M, Katagiri N, Ueda M, Tanaka S. Functional analysis of Nkx2.1 and Pax9 for calcitonin gene transcription. Gen Comp Endocrinol. 152(2-3):259-266.
35. Tverberg LA, Russo AF. Regulation of the calcitonin/calcitonin gene-related peptide gene by cell-specific synergy between helixloop-helix and octamer-binding transcription factors. J Biol Chem. 1993;268(21):15965-15973.
36. Elyada E, Pribluda A, Goldstein RE, et al. CKIα ablation highlights a critical role for p53 in invasiveness control. Nature. 2011;470(7334):409-413.
37. Dadras SS, Skrzypek A, Nguyen L, et al. Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol. 2008;128(12):2798-2806.
38. Liu Y, Zhang JB, Qin Y, et al. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1 α expression and protein stability. Hepatology. 2013;58(2):692-705.
39. Lv T, Liu Y, Zhang J, etal. Impact of an altered PROX1 expression on clinicopathology, prognosis and progression in renal cell carcinoma. PLoS One. 2014;9(5):e95996.
40. Ahmed SR, Ball DW. Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment. J Clin Endocrinol Metab. 2011;96(5):1237-1245.
41. Sand M, Gelos M, Sand D, et al. Serum calcitonin negative medullary thyroid carcinoma. World J Surg Oncol. 2006;4:97.